Levaquin and Cipro Add Increased Warnings
This Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. The safety profile of the class of drugs which include Levaquin, Cipro, Avelox, Noroxin, Floxin and Factive just keeps getting worse. Today the FDA has required the drug labels and Medication Guides for all fluoroquinolone antibacterial drugs be updated to better describe
Read MoreConsumer Alert! Risperdal Gynecomastia Dangers!
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Well, the sad fact is that Johnson & Johnson is at it again. This time around it involves the drug Risperdal. The even sadder part is that the victims are innocent, adolescent males. Risperdal is an antipsychotic drug used to treat
Read MoreConsumer Alert! Lipitor Diabetes Warning!
Recently, the Food and Drug Administration (FDA) began requiring manufacturers of cholesterol-lowering statin drugs to place warning labels on their products alerting consumers and medical providers to an increased risk of developing Type 2 diabetes. Statins have been available to treat high cholesterol since the 1980s, but purportedly only recently was the link between statins and diabetes discovered (at least that is what the manufacturers claim, and I have serious doubts). The warning labels come in the wake of several large-scale studies that revealed the risks associated with taking statins are far greater than what the statin industry previously advised the public and medical community.
Read More